Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 9, 2026

Feb. 9, 2026

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

GlobeNewswire

Feb. 9, 2026

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

GlobeNewswire

Feb. 9, 2026

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

GlobeNewswire

Feb. 9, 2026

Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

GlobeNewswire

Feb. 9, 2026

Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium

GlobeNewswire

Feb. 9, 2026

Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026

GlobeNewswire

Feb. 9, 2026

Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones

GlobeNewswire

Feb. 9, 2026

Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy

GlobeNewswire

Feb. 9, 2026

QuantX Biosciences Closes Oversubscribed $85M Series B Financing

GlobeNewswire

Feb. 9, 2026

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

GlobeNewswire

Feb. 9, 2026

Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial

GlobeNewswire

Feb. 9, 2026

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

GlobeNewswire

Feb. 9, 2026

Celldex to Present at Upcoming Investor Conferences

GlobeNewswire

Feb. 9, 2026

ProQR Announces Planned Changes to Board Composition

GlobeNewswire

Feb. 9, 2026

The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)

GlobeNewswire

Feb. 9, 2026

Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain

GlobeNewswire

Feb. 9, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 9, 2026

Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

GlobeNewswire

Feb. 9, 2026

Voyager to Present at Upcoming Investor Conferences

GlobeNewswire

Feb. 9, 2026

Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire